CERVARIX Trademark

Trademark Overview

On Thursday, November 10, 2005, a trademark application was filed for CERVARIX with the United States Patent and Trademark Office. The USPTO has given the CERVARIX trademark a serial number of 78751441. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 28, 2009. This trademark is owned by GlaxoSmithKline Biologicals, S.A.. The CERVARIX trademark is filed in the Pharmaceutical Products category with the following description:

VACCINES FOR HUMAN USE
cervarix

General Information

Serial Number78751441
Word MarkCERVARIX
Filing DateThursday, November 10, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 28, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 6, 2006

Trademark Statements

Indication of Colors claimedThe colors white, pink and orange are claimed as a feature of the mark.
Description of the Colors ClaimedThe colors white, pink and orange appear in the starburst design and the color pink appears in the lettering of the term CERVARIX.
Description of MarkThe mark is comprised of the term CERVARIX and a starburst design on the right hand side of the term CERVARIX.
Goods and ServicesVACCINES FOR HUMAN USE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 16, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Monday, September 28, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 28, 2009ABANDONMENT - NO USE STATEMENT FILED
Monday, January 26, 2009EXTENSION 5 GRANTED
Monday, January 26, 2009EXTENSION 5 FILED
Monday, January 26, 2009TEAS EXTENSION RECEIVED
Friday, July 25, 2008EXTENSION 4 GRANTED
Friday, July 25, 2008EXTENSION 4 FILED
Friday, July 25, 2008TEAS EXTENSION RECEIVED
Thursday, May 1, 2008ASSIGNED TO EXAMINER
Tuesday, January 8, 2008EXTENSION 3 GRANTED
Tuesday, January 8, 2008EXTENSION 3 FILED
Tuesday, January 8, 2008TEAS EXTENSION RECEIVED
Tuesday, July 24, 2007EXTENSION 2 GRANTED
Tuesday, July 24, 2007EXTENSION 2 FILED
Tuesday, July 24, 2007TEAS EXTENSION RECEIVED
Tuesday, January 16, 2007EXTENSION 1 GRANTED
Tuesday, January 16, 2007EXTENSION 1 FILED
Tuesday, January 16, 2007TEAS EXTENSION RECEIVED
Tuesday, August 29, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2006NOTICE OF PUBLICATION
Wednesday, April 19, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 17, 2006ASSIGNED TO LIE
Thursday, March 23, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 23, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, March 23, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, March 23, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 8, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 28, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 28, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2005NON-FINAL ACTION E-MAILED
Monday, December 12, 2005NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2005ASSIGNED TO EXAMINER
Thursday, November 17, 2005NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, November 16, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

cervarix human vaccines